Abstract
Chronic kidney disease is one of a major health problem both nationally and globally due to the tendency of the patient has been increased annually. At an early stage of chronic kidney disease, the patient has no symptom, but the diagnosis is possible by analyze an amount of microalbumin in urine and combine with serum creatinine. However, this process is allowed at the hospital only. To enable an effective and extensive access for a high-risk of chronic kidney disease population, this project focuses on using a urine microalbumin screening test kit for screening the chronic kidney disease at an early stage and including data storage in an online database for easily follow up and proper treatment planning. From the screening of a high-risk of chronic kidney disease population and asymptomatic at Ban Phaeo District in Samut Sakhon province, the 595 volunteers or 25.72% out of the 2,313 volunteers in total was suspected of chronic kidney disease. After 3 months follow-up, 178 patients (out of 260 volunteers) still had renal dysfunction that met the criteria for diagnosis of chronic kidney disease. The estimated prevalence of chronic kidney disease was 17.5%, which is similar to the prevalence in a general population from the Thai-SEEK project. The urine microalbumin screening test kit provides 96% accuracy, 86% sensitivity, and 98% specificity that indicated an efficient, highly accurate, convenient to use, and the results can be read rapidly. It can be used outside the laboratory which enable to reach high-risk populations. Moreover, it also possesses the potential for further commercial use.
